To determine your specific coverage, we recommend contacting your insurance provider directly
Limitations of approved use For example, VYLEESI is not indicated for: First, Postmenopausal women Next, Men Also, Enhancement of sexual performance Moreover, Treatment of erectile dysfunction In addition, Low desire caused by another medical or psychiatric condition Likewise, Low desire caused by relationship problems or medication effects Unregulated product concerns However, products sold as PT-141 outside regulated pharmaceutical channels may differ in peptide identity, salt form, concentration, sterility, endotoxin burden, residual solvents, degradation products, and dose uniformity
2023 international evidence-based polycystic ovary syndrome guideline update: insights from a systematic review and meta-analysis on elevated clinical cardiovascular disease in polycystic ovary syndrome
Weight loss injection pens that mimic the action of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) hormones help regulate appetite, improve metabolism, and promote fat reduction